Design of an Anti-HMGB1 Synthetic Antibody for <i>In Vivo</i> Ischemic/Reperfusion Injury Therapy-Reference-Cited by-同舟云学术

Design of an Anti-HMGB1 Synthetic Antibody for In Vivo Ischemic/Reperfusion Injury Therapy

Published:2023-10-16 Issue:42 Volume:145 Page:23143-23151
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Koide Hiroyuki¹^ORCID,Kiyokawa Chiaki¹,Okishima Anna¹,Saito Kaito¹,Yoshimatsu Keiichi²^ORCID,Fukuta Tatsuya¹^ORCID,Hoshino Yu³,Asai Tomohiro¹,Nishimura Yuri³,Miura Yoshiko³^ORCID,Oku Naoto¹,Shea Kenneth J.⁴^ORCID

Affiliation:

1. Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan

2. Department of Chemistry, Missouri State University, 901 South National Avenue, Springfield, Missouri 65897, United States

3. Department of Chemical Engineering, Kyushu University, 744 Motooka, Fukuoka 819-0395, Japan

4. Department of Chemistry, University of California Irvine, Irvine, California 92697, United States

Funder

Japan Society for the Promotion of Science

Mochida Memorial Foundation for Medical and Pharmaceutical Research

Division of Materials Research

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/jacs.3c06799

Reference50 articles.

1. Therapeutic antibodies: successes, limitations and hopes for the future

2. Abstract

3. Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics

4. Discovery of a Highly Specific Anti-methotrexate (MTX) DNA Aptamer for Antibody-Independent MTX Detection

5. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease